Page 3 - Dr Reddy's Laboratories Limited

Dr Reddy's hits 52-week high after USFDA issues EIR for Srikakulam facility

The company said, with this, all facilities under warning letter are now determined as Voluntary Action Indicated (VAI)

India gears up for patient trials on 20 different drugs for Covid-19

Local pharma units have already started work on developing patented drugs, some have already approached regulator for approvals

Dr Reddy's denies reports it is in talks with Gilead for Covid-19 antiviral

Patient groups urge govt to revoke Gilead's remedesivir patent in the wake of the crisis

Dr Reddy's launches generic Ziprasidone Mesylate for injection in US

It's the therapeutic generic equivalent of Geodon Injections

Dr Reddy's gets 1 observation from USFDA after inspecting Hyderabad plant

Earlier, the drug major had said that the US health regulator has issued a Form 483 with two observations after inspecting the facility but later it was issued revised Form 483 with one observation

Dr Reddy's gets nod for amalgamation of Dr Reddy's Holdings into company

21,026 votes, which accounted for the rest 0.02 per cent, were posted against the resolution, it added

China opens public hospitals for Dr Reddy's Laboratories generic drugs

First Indian firm to get contract for supplying generic schizophrenia drug to public hospitals there

PSAI segment decline pulls down Dr Reddy's Q1 show

Earnings were driven by one-off gains

Dr Reddy's recalls cholesterol lowering Atorvastatin tablets in the US

The company initiated a voluntary recall of 2,280 bottles of Atorvastatin Calcium 40 mg 500 tablets on August 2